Viemed Healthcare (NASDAQ:VMD) Upgraded at Wall Street Zen

Viemed Healthcare (NASDAQ:VMD) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

VMD has been the topic of several other reports. Zacks Research raised Viemed Healthcare to a “hold” rating in a report on Thursday, January 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Viemed Healthcare in a research report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Viemed Healthcare Stock Up 1.5%

VMD opened at $8.28 on Friday. The stock has a market capitalization of $314.81 million, a price-to-earnings ratio of 25.09 and a beta of 1.27. The firm has a 50 day moving average price of $7.53 and a 200-day moving average price of $7.02. Viemed Healthcare has a twelve month low of $5.93 and a twelve month high of $8.94. The company has a quick ratio of 1.01, a current ratio of 1.13 and a debt-to-equity ratio of 0.14.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new position in shares of Viemed Healthcare during the 4th quarter valued at approximately $25,000. Quarry LP purchased a new stake in Viemed Healthcare in the 3rd quarter valued at about $48,000. AQR Capital Management LLC bought a new position in Viemed Healthcare in the 1st quarter worth about $90,000. SG Americas Securities LLC purchased a new position in shares of Viemed Healthcare during the fourth quarter worth approximately $101,000. Finally, R Squared Ltd purchased a new position in shares of Viemed Healthcare during the fourth quarter worth approximately $102,000. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.